Metabolic syndrome components increase endometrial cancer risk

Article

A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome beyond simply being overweight, according to a case-control study.

A direct association exists between endometrial cancer risk and individual components of the metabolic syndrome (MetS) beyond simply being overweight, according to a case-control study of more than 1,200 women in Italy.

Researchers found that women with type 2 diabetes mellitus were more than twice as likely as those without the disease to develop endometrial cancer (odds ratio [OR], 2.18).

In addition, the ORs for developing endometrial cancer were 1.77 for women with hypertension, 1.20 for women with hyperlipidemia, between 1.62 and 2.23 for women who fit various definitions of central obesity, and 3.83 for women with a body mass index (BMI) greater than 30 kg/m2.

Rosato V, Zucchetto A, Bosetti C, et al. Metabolic syndrome and endometrial cancer risk. Ann Oncol. October 11, 2010. Epub ahead of print.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Haluk Damgacioglu, PhD, discusses cervical cancer's link to anal cancer risk | Image Credit: cadsci.com.
Natalia Llarena, MD, discusses rising fertility anxiety in Gen Z | Image Credit: havingbabies.com.
Uma Mahadevan, MD, highlights new guidelines for managing IBD | Image Credit: ucsfhealth.org.
© 2025 MJH Life Sciences

All rights reserved.